<- Go Home
Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Market Cap
EUR 2.7B
Volume
4.1K
Cash and Equivalents
EUR 128.7M
EBITDA
EUR 262.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 955.9M
Profit Margin
66.72%
52 Week High
EUR 400.00
52 Week Low
EUR 249.70
Dividend
0.46%
Price / Book Value
2.50
Price / Earnings
20.00
Price / Tangible Book Value
4.63
Enterprise Value
EUR 2.8B
Enterprise Value / EBITDA
10.32
Operating Income
EUR 212.3M
Return on Equity
12.93%
Return on Assets
7.35
Cash and Short Term Investments
EUR 138.5M
Debt
EUR 325.6M
Equity
EUR 1.1B
Revenue
EUR 1.4B
Unlevered FCF
EUR 104.0M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium